| 1 |
郑琪, 胡雪玲, 廖子君, 等.以骨转移为首发症状的胃癌24例临床特点分析[J/CD].消化肿瘤杂志(电子版), 2018, 10(4): 231-234.
|
| 2 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 3 |
Li X, Liu S, Yan J, et al. The characteristics, prognosis, and risk factors of lymph node metastasis in early gastric cancer [J]. Gastroenterol Res Pract, 2018, 2018: 6945743.
|
| 4 |
郑潇豪, 解亦斌. 中国晚期胃癌的诊疗现状 [J]. 癌症进展, 2019, 17(1): 13-19, 48.
|
| 5 |
徐文杰, 周建奖.胃癌转移的研究进展[J/CD].中华临床医师杂志(电子版), 2011, 5(1): 170-173.
|
| 6 |
Kobayashi M, Okabayashi T, Sano T, et al. Metastatic bone cancer as a recurrence of early gastric cancer-characteristics and possible mechanisms [J]. World J Gastroenterol, 2005, 11(9): 5587-5591.
|
| 7 |
Turkoz FP, Solak M, Kilickap S, et al. Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival [J]. J Gastric Cancer, 2014, 14(3): 164-172.
|
| 8 |
Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey [J]. PLoS One, 2013, 8(10): e74402.
|
| 9 |
郑翰林, 申鹏飞, 朱腾飞, 等.骨转移癌217例临床分析[J].实用医学杂志, 2017, 33(18): 3070-3074.
|
| 10 |
Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients [J]. J Gastric Cancer, 2011, 11(1): 38-45.
|
| 11 |
Park JM, Song KY, O JH, et al. Bone recurrence after curative resection of gastric cancer [J]. Gastric Cancer, 2013, 16(3): 362-369.
|
| 12 |
Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey [J]. PLoS One, 2013, 8(10): e74402.
|
| 13 |
万伟, 李双妮, 张学成, 等. 胃癌骨转移60例临床病理特点及预后因素分析[J].实用癌症杂志, 2018, 33(12): 2026-2029.
|
| 14 |
Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey [J]. PLoS One, 2013, 8(10): e74402.
|
| 15 |
Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies [J]. J Pathol, 1986, 150(3): 195-203.
|
| 16 |
Kim JH, Kim N. Signaling pathways in osteoclast differentiation [J].Chonnam Med J, 2016, 52(1): 12-17.
|
| 17 |
Haider M, Taipaleenmaki H. Targeting the metastatic bone microenvironment by microRNAs [J]. Front Endocrinol (Lausanne), 2018, 9: 202.
|
| 18 |
Mikami J, Kimura Y, Makari Y, et al. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis [J]. World J Surg Oncol, 2017, 15(1): 8.
|
| 19 |
Nakamura K, Tomioku M, Nabeshima K, et al. Clinicopathologic features and clinical outcomes of gastric cancer patients with bone metastasis [J]. Tokai J Exp Clin Med, 2014, 39(4): 193-198.
|
| 20 |
Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer: a phase 3, open-label, randomised controlled trial [J]. Lancet, 2010, 376(9742): 687-697.
|